Back Pain Doctor
Carpal Tunnel Syndrome
Written by Dr Joshua Hatch, Musculoskeletal GP, RACGP Fellow, Diploma in Musculoskeletal Medicine (FSEM UK).
Carpal tunnel syndrome is a common nerve entrapment condition at the wrist. Symptoms often occur at night or during activities that involve gripping, vibration or sustained wrist position.
Assessment focuses on confirming whether the median nerve is the likely source and checking for weakness, muscle wasting or other neurological findings. Other causes of hand symptoms, including cervical radiculopathy, need to be considered when the pattern is unclear.
Non-surgical care may include night splinting, reducing aggravating loads, ergonomic changes and selected ultrasound-guided procedures. Persistent or progressive neurological deficit needs timely review because prolonged nerve compression can become harder to reverse.
Common symptoms
- Numbness or tingling in the thumb, index, middle or ring finger
- Symptoms that wake people at night or are worse with gripping
- Hand weakness, clumsiness or dropping objects
- Symptoms aggravated by driving, phone use, typing or tools
Evidence for twelve treatment options in carpal tunnel syndrome
This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.
Foundation: diagnosis, education and rehabilitation
The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.
Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Core care
What it involves
Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan, with weight management where that is clinically relevant.
What the evidence shows
Conservative care comes first, and it holds up well. A network meta-analysis of 49 randomised trials and 3,323 patients with carpal tunnel syndrome ranked manual therapy first for both short- and medium-term pain relief, ahead of every injection option including corticosteroid (Chen, Arch Phys Med Rehabil 2025).
Pairing reviewed 2026-09-02.
Where it fits
Load management, splinting where it fits, and addressing what is irritating the nerve come before any injection. Where the nerve is being compressed structurally and function is being lost, surgical review is the right conversation rather than more conservative care.
Muscle and symptom-modifying options
Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.
Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. Dry needling trials, no sham
What it involves
The needle is placed into the tender muscle band and a small volume of 5% glucose with a very dilute local anaesthetic (0.02-0.08%) is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling (the same technique with nothing injected) is not offered here.
What the evidence shows
Three randomised trials have tested needling of the forearm and thumb muscles in carpal tunnel syndrome, all with a needle and no injectate, and none against a true sham. In 30 manual workers, two sessions of dry needling to the thenar muscles improved symptom scores and grip and pinch strength at two weeks compared with a waiting list, with motor nerve conduction unchanged (Rezazadeh, Physiother Theory Pract 2022). In 86 wrists already recommended for surgery, six weekly sessions of dry needling reduced the proportion still recommended for surgery at 12 weeks by 62% (relative risk 0.38, 95% CI 0.20 to 0.72) against staying on the waiting list, without changing nerve conduction or ultrasound findings (Gascon-Garcia, J Bodyw Mov Ther 2025). In 75 people, seven weekly sessions of deep needling into the pronator teres muscle improved pain, grip and the clinical nerve tests more than a shallow needle at an acupuncture point, though the size of the median nerve fell similarly in both groups; the trial was registered after it began (Kvist, J Bodyw Mov Ther 2021). A 2025 review judged the needling evidence in carpal tunnel syndrome insufficient and at high risk of bias (Zhu, J Pain Res 2025). The injected form of this row has one case report, in a woman with median and ulnar nerve entrapment and coexisting muscle pain whose symptoms settled over eight sessions of trigger point injection (Medina, Pain Med Case Rep 2026); a November 2026 search found no trial of it.
Pairing reviewed 2026-11-05.
Where it fits
Directed at tender bands in the thumb and forearm muscles that can mimic or add to the nerve symptoms, and used to make hand and forearm loading more comfortable, not to replace it. It does not release the nerve, and the trials behind it used a needle without an injectate.
Ultrasound-guided injections Guidance means the needle can be seen reaching the target. What goes into the needle depends on the diagnosis. Good support
What it involves
The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis, and corticosteroid is used sparingly, for the reasons set out below.
What the evidence shows
At the carpal tunnel, ultrasound guidance itself has been tested, not just assumed. A meta-analysis of nine randomised trials in 469 people (596 hands) found guided corticosteroid injection better than a landmark-guided one for symptom severity (SMD -0.69, 95% CI -1.08 to -0.31) and function (-0.23, -0.39 to -0.07), with roughly a third the rate of adverse events (RR 0.34, 0.22 to 0.52) (Wang, Clin Rehabil 2021). What goes in the needle is a separate question: in a double-blind randomised trial of 36 people, a single ultrasound-guided injection of 5% dextrose and one of methylprednisolone both improved pain, symptom scores and median nerve cross-sectional area over three months, with no difference between them (Nasiri, Neurol Res 2023).
Pairing reviewed 2026-09-10.
Where it fits
Useful for short-term relief, and to confirm the diagnosis when the picture is not clear-cut. It does not decompress the nerve, so where strength is being lost or symptoms keep returning, surgical review is the right conversation. Guidance is the part with the clearest evidence here.
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Plausible: no studies
What it involves
A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.
What the evidence shows
No published clinical trial of this device in this condition. It is a vibration handpiece delivered from the same console as radial shockwave, and the rationale is myofascial rather than tendon- or bone-directed.
Pairing reviewed 2026-08-30.
Where it fits
A comfort measure used within a session where muscular tightness is limiting movement. Never the reason for the appointment, and not a substitute for the treatments that do have evidence.
Energy-based treatment options
Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.
Radial or focused shockwave? Read the overviewRadial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. Short-term evidence
What it involves
A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue, including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.
What the evidence shows
Radial shockwave has beaten a sham treatment in carpal tunnel syndrome in two independent double-blind trials. In Taiwan, 34 people (40 wrists) had three sessions of radial shockwave or sham, all with a night splint, and the shockwave group had less pain, better Boston questionnaire scores and a smaller swollen median nerve on ultrasound from one to twelve weeks (Wu, J Orthop Res 2016); the same group found three sessions beat sham to at least 14 weeks in 90 wrists, but a single session did no better than sham (Ke, Sci Rep 2016). In Turkey, 45 people (66 wrists) with mild to moderate disease had radial shockwave or sham alongside splints and nerve-gliding exercises; at one month pain on a 10-point scale was 3.5 against 6.6, with better nerve conduction (Menekseoglu, Rev Assoc Med Bras 2023). A meta-analysis of ten trials (433 people, 501 wrists) found shockwave improved pain (mean difference -0.60 points, 95% CI -1.16 to -0.05), symptoms and hand function, and on subgroup analysis the radial device was effective and the focused device was not (Xie, Disabil Rehabil 2022). Not every trial agrees, and the benefit is mostly short term. A meta-analysis of seven trials (376 people) that compared shockwave plus a night splint with the splint alone found an advantage at four weeks that was no longer significant at 8 to 14 weeks (Chen, Medicina 2022). Radial shockwave added nothing to a splint in a 40-person trial (Raissi, Ultrasound Med Biol 2017), a single session added nothing to a PRP injection against sham (Chang, Pain Med 2020), and in a 72-person trial a steroid injection did better than radial shockwave, which showed no clear advantage over a splint alone (Öztürk Durmaz, Am J Phys Med Rehabil 2022). The overall certainty is rated low (Zhang, J Clin Med 2023). Side effects reported are minor: brief tingling or soreness.
Pairing reviewed 2026-10-28.
Where it fits
A reasonable option in mild to moderate carpal tunnel syndrome, usually three weekly sessions alongside a night splint and nerve-gliding exercises, particularly if you would rather avoid an injection. Expect a modest improvement over weeks to about three months; one session is not enough, and what happens beyond six months is not well studied. Progressive weakness or wasting of the thumb muscles needs a surgical opinion rather than more conservative treatment.
Focused shockwave (ESWT) A true shock wave converging at depth: for tendon, joint, ligament and bone. Evidence mixed
What it involves
A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form used for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.
What the evidence shows
Focused shockwave has been tested in carpal tunnel syndrome, and the trials disagree. The only sham-controlled trial of a clearly focused device, a 30-person pilot in Vienna with 20 people analysed, found pain improved within the shockwave group, but the full report shows no significant difference from sham on pain or on any outcome once multiple testing was allowed for (Gesslbauer, Wien Klin Wochenschr 2021). Against conservative care alone (splint, exercises) without a sham, focused shockwave did better in 60 people with moderate disease at three and six months (Vahdatpour, Adv Biomed Res 2016) and in 24 people with moderate to severe disease at three and six weeks (Vongvachvasin, J Rehabil Med 2024). Against active treatments the results are split: no better than a steroid injection on symptoms, with nerve conduction favouring the injection (Seok, Am J Phys Med Rehabil 2013), better than therapeutic ultrasound for pain at 12 weeks (Paoloni, Eur J Phys Rehabil Med 2015), and no better than a nutritional supplement (Notarnicola, Int J Immunopathol Pharmacol 2015). On meta-analysis the focused device was not significantly effective in one review (Xie, Disabil Rehabil 2022) and effective in another rated low certainty (Zhang, J Clin Med 2023). Searched 28 October 2026: PubMed, shockwave terms with carpal tunnel, randomised-trial and systematic-review passes.
Pairing reviewed 2026-10-28.
Where it fits
Not the shockwave device of first choice here: the radial device has the stronger controlled evidence in this condition. Focused treatment may be considered in mild to moderate cases where someone wants to avoid or delay an injection or surgery, alongside a night splint and nerve-gliding exercises.
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Usually painless, no contact. Plausible: no studies
What it involves
You sit with the applicator positioned over the area for a short session. It is usually painless and needs no gel or skin contact. It is usually given as a course, commonly alongside shockwave.
What the evidence shows
There are no published randomised trials of EMTT in this condition, or in any musculoskeletal condition, that could be identified. The supporting work is laboratory work: EMTT increased tenocyte proliferation, migration and collagen expression in cultured human tendon cells (Mancini, Int J Mol Sci 2025). The nearest human evidence for a related electromagnetic therapy is negative. A randomised trial of pulsed electromagnetic field therapy added to eccentric exercise for Achilles tendinopathy found no improvement in outcome scores or tendon neovascularity over eccentric exercise alone (Ko, Orthop J Sports Med 2024).
Pairing reviewed 2026-08-30.
Where it fits
Offered only as an adjunct alongside treatment that does have evidence, never as the plan itself, and only after that gap is explained. Much of the EMTT literature is manufacturer-affiliated, which is part of why it is described this way.
Biologic and joint injection options
Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.
Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. Worth discussing
What it involves
Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.
What the evidence shows
Carpal tunnel is the one place platelet-rich plasma separates from placebo in a systematic review. Across 33 randomised trials in six conditions it made no difference in lateral epicondylitis, plantar fasciitis, Achilles, rotator cuff or patellar tendinopathy, but in carpal tunnel, pain scores at 3 and 6 months and symptom severity at 1, 3 and 6 months were better than controls (Masiello, Blood Transfus 2022), with the certainty graded low. A network meta-analysis of 49 trials and 3,323 patients ranked manual therapy first, with 5% glucose and platelet-rich plasma close behind (Chen, Arch Phys Med Rehabil 2025).
Pairing reviewed 2026-09-06.
Where it fits
A reasonable option, but not the first one. In that same network analysis 5% glucose perineural injection ranked above it, costs less and is the treatment this practice has the most evidence for, so it is offered first, and platelet-rich plasma is discussed if that has not worked.
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. Not offered for this
What it involves
Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.
What the evidence shows
The dextrose evidence in carpal tunnel is for a different injection. In a network meta-analysis of 49 randomised trials and 3,323 patients, 5% glucose in water ranked just behind manual therapy for pain relief (Chen, Arch Phys Med Rehabil 2025), and in a network meta-analysis of nine hydrodissection studies in 458 patients it ranked top for function at 4, 12 and 24 weeks (Lee, Yonsei Med J 2025). That is dilute glucose placed around the nerve: the perineural and hydrodissection rows on this page. No trial of prolotherapy in its usual sense, stronger dextrose at ligament and tendon attachments, was found in carpal tunnel syndrome.
Pairing reviewed 2026-09-03.
Where it fits
Not offered for this. The problem at the wrist is a compressed nerve rather than a lax ligament, and the dextrose treatment that does help here is the dilute perineural one described elsewhere on this page.
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. Not used here
What it involves
One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.
What the evidence shows
There is no joint here to viscosupplement, but hyaluronic acid itself has been tested at the carpal tunnel, as the fluid used to hydrodissect around the median nerve rather than as a joint injection. In a double-blind randomised trial of 35 people with mild to moderate carpal tunnel syndrome (32 completing) it beat salt water on symptom and pain scores only at two weeks, with no advantage at one, three or six months (Su, Pain Med 2021), and in a comparison of four injection fluids in 61 severe cases it trailed dextrose and platelet-rich plasma on Boston questionnaire scores at one and six months (Wu, Biomed Res Int 2022). A hyaluronic acid anti-adhesion gel used at carpal tunnel release surgery gave no symptomatic or functional advantage in 200 patients at one year (Bilge, Acta Chir Orthop Traumatol Cech 2017). That evidence belongs with hydrodissection, not with joint viscosupplementation.
Pairing reviewed 2026-09-12.
Where it fits
Not offered as a joint injection for this problem. Where the aim is fluid placed around the nerve, that is discussed under hydrodissection.
Nerve-targeted options
Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve, not simply because pain is present.
Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. Good support
What it involves
Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.
What the evidence shows
The strongest evidence for any injection offered here. In mild to moderate carpal tunnel syndrome, ultrasound-guided perineural 5% dextrose beat saline for pain, disability, nerve conduction and median nerve cross-sectional area at 1, 3 and 6 months (Wu, Mayo Clin Proc 2017), and beat corticosteroid from month 4 to month 6 (Wu, Ann Neurol 2018). A meta-analysis of 5 studies and 212 patients found dextrose better than corticosteroid for functional status within 3 months with far fewer adverse events (risk ratio 0.13) (Oh, Arch Phys Med Rehabil 2024). A follow-up of 185 patients reported 88.6% still reporting an effective outcome 1 to 3 years later, after an average of 2.2 injections (Li, Rheumatology 2020).
Pairing reviewed 2026-08-30.
Where it fits
A genuine alternative to corticosteroid or surgery in mild to moderate disease. Severe compression, wasting or weakness still needs a surgical opinion.
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Good support
What it involves
Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.
What the evidence shows
The strongest evidence for any injection offered here. In mild to moderate carpal tunnel syndrome, ultrasound-guided perineural 5% dextrose beat saline for pain, disability, nerve conduction and median nerve cross-sectional area at 1, 3 and 6 months (Wu, Mayo Clin Proc 2017), and beat corticosteroid from month 4 to month 6 (Wu, Ann Neurol 2018). A meta-analysis of 5 studies and 212 patients found dextrose better than corticosteroid for functional status within 3 months with far fewer adverse events (risk ratio 0.13) (Oh, Arch Phys Med Rehabil 2024). A follow-up of 185 patients reported 88.6% still reporting an effective outcome 1 to 3 years later, after an average of 2.2 injections (Li, Rheumatology 2020).
Pairing reviewed 2026-08-30.
Where it fits
A genuine alternative to corticosteroid or surgery in mild to moderate disease. Severe compression, wasting or weakness still needs a surgical opinion.
This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.
Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target. The method behind the ratings, and the treatments not offered, are set out on the evidence page.
Corticosteroid injection is reviewed separately for each diagnosis.
Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.
So treatment plans are not built around it. Where an injection is the right call, the specific diagnosis and target are reviewed, what is being injected and why is discussed, the number is kept low, and it is paired with the loading work that changes the longer-term course.
When it might still be considered
- Pain severe enough to block rehabilitation
- A clear inflammatory or bursal target on imaging
- A specific short-term goal: a trip, a procedure, a return to work
- Diagnostic use, where the response shows where the pain is coming from
When a cortisone injection is worth doing, and when it is not
Other elbow, wrist & hand conditions
Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.
Related articles
Shorter articles that answer the questions patients ask most often about this.
- Carpal Tunnel Syndrome: Do You Need Surgery?Carpal tunnel syndrome often settles without surgery. When a night splint helps, and which numbness or weakness needs prompt review in Brisbane.
- Wrist Pain: Exploring the Causes, Symptoms, and Treatment OptionsFractures, sprains, osteoarthritis, rheumatoid arthritis and carpal tunnel syndrome all cause wrist pain. How each is distinguished and managed.
Frequently asked questions
How is carpal tunnel syndrome diagnosed?
When is surgery needed?
Can non-surgical treatment help?
Ready for a clearer plan for your back or musculoskeletal pain?
Book an assessment with Dr Joshua Hatch.
Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.
You must have your own regular GP before booking. This service works alongside your GP for focused care. Booking requirements.
Book an appointment